drugset / Trial / NCT05011760
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
NaSingle-groupOpen-labelBasic science
Summary
This study uses \[11C\]NPA positron emission tomography (PET) and a d-amphetamine challenge to image amphetamine induced dopamine release in the striatum in subjects with cocaine use disorders (CUD). Amphetamine-induced dopamine release data from this study will be correlated with \[11C\]NOP-1A VT measured at baseline in the midbrain. \[11C\]NOP-1A PET data will be used from aim 1 (see, Study Record: Imaging CRF X NOP interactions in Cocaine Use Disorders)
Timeline
- Start
- 2021-01-31
- Primary completion
- 2028-09-01
- Completion
- 2028-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextroamphetamine | Small molecule | 0.5 mg/kg | Oral |